4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-033681
Chief Financial Officer acquired 6,230 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran Chief Financial Officer | 2023-05-31 | Grant or award | +6,230 | 291,042 | D |
Loading xslF345X04/doc4.xml…